Jazz Pharmaceuticals Financial Overview
Jazz Pharmaceuticals's market cap is currently $8.80B. The company's EPS TTM is €6.9326129496; its P/E ratio is -26.63; Jazz Pharmaceuticals is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €5.45. See an overview of income statement, balance sheet, and cash flow financials.
